New Biomarker PYCR1 for Sinonasal Squamous Cell Carcinoma
Author Information
Author(s): Panthong Watcharapong, Pientong Chamsai, Nukpook Thawaree, Roytrakul Sittiruk, Yingchutrakul Yodying, Teeramatwanich Watchareporn, Aromseree Sirinart, Ekalaksananan Tipaya, Iavarone Federica
Primary Institution: Khon Kaen University
Hypothesis
Can proteomic analysis combined with machine learning identify biomarkers for predicting the prognosis of sinonasal squamous cell carcinoma (SNSCC)?
Conclusion
The study identified PYCR1 as a potential prognostic biomarker for SNSCC, with high expression linked to poor overall survival.
Supporting Evidence
- Seventeen feature proteins were identified as potential biomarkers for SNSCC.
- PYCR1 expression was confirmed to be significantly higher in SNSCC tissues compared to nasal polyps.
- High PYCR1 expression was associated with poor overall survival in SNSCC patients.
Takeaway
Researchers found a new marker called PYCR1 that can help doctors predict how patients with a rare nose cancer will do.
Methodology
Proteomic analysis was performed on tissue samples from SNSCC and nasal polyps, followed by machine learning classification to identify potential biomarkers.
Potential Biases
Age differences could introduce bias in the results, as proteomic profiles may reflect age-related changes rather than disease-specific differences.
Limitations
The study had a small sample size and significant age differences between groups, which may affect biomarker identification.
Participant Demographics
Patients were primarily aged 50-60 years, with a higher incidence in men than women.
Statistical Information
P-Value
p < 0.0001
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website